Masayuki Yokoyama

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Structure Activity Relationship

Top Venues

Magma (New York, N.Y.)

Molecular pharmaceutics

The Jikei University School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The Jikei University School of Medicine

Japan

Head :: Division of Medical Engineering

Publications

Debabrata Maiti, Masayuki Yokoyama, Kouichi Shiraishi
Impact of the Hydrophilicity of Poly(sarcosine) on Poly(ethylene glycol) (PEG) for the Suppression of Anti-PEG Antibody Binding. ACS omega 9 (32) (2024)
Debabrata Maiti, Masayuki Yokoyama, Kouichi Shiraishi
Impact of the Hydrophilicity of Poly(sarcosine) on Poly(ethylene glycol) (PEG) for the Suppression of Anti-PEG Antibody Binding. ACS omega 9 (32) (2024)
Satoshi Okada, Kai Nishimura, Qarri Ainaya, Kouichi Shiraishi, Sergey A Anufriev, Igor B Sivaev, Yoshinori Sakurai, Minoru Suzuki, Masayuki Yokoyama, Hiroyuki Nakamura
Development of a Gadolinium-Boron-Conjugated Albumin for MRI-Guided Neutron Capture Therapy. Molecular pharmaceutics (2023)
Masayuki Yokoyama, Kouichi Shiraishi
Stability evaluation of Gd chelates for macromolecular MRI contrast agents. Magma (New York, N.Y.) 33 (4) (2019)